Evidence map›Paper›PMID 37761966›Full record

ArticleGenes2023

Functional Variation in the

Lisa Bornscheuer, Andreas Lundin, Yvonne Forsell, Catharina Lavebratt, Philippe A Melas

Open access · goldAbstract read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lisa BornscheuerDepartment of Public Health Sciences, Stockholm University, 10691 Stockholm, Sweden.
Andreas LundinDepartment of Global Public Health, Karolinska Institutet, 17177 Stockholm, Sweden.
Yvonne ForsellDepartment of Global Public Health, Karolinska Institutet, 17177 Stockholm, Sweden.
Catharina LavebrattDepartment of Molecular Medicine and Surgery, Karolinska Institutet, 17176 Stockholm, Sweden.ORCID 0000-0003-4987-2718
Philippe A MelasCenter for Molecular Medicine, L8:00, Karolinska University Hospital, 17176 Stockholm, Sweden.ORCID 0000-0002-7889-9250
Karolinska Institutet · SEKarolinska University Hospital · SEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatty acid amide hydrolase (FAAH) is an enzyme that degrades anandamide, an endocannabinoid that modulates mesolimbic dopamine release and, consequently, influences states of well-being. Despite these known interactions, the specific role of FAAH in subjective well-being remains underexplored. Since well-being is a dynamic trait that can fluctuate over time, we hypothesized that we could provide deeper insights into the link between FAAH and well-being using longitudinal data. To this end, we analyzed well-being data collected three years apart using the WHO (Ten) Well-Being Index and genotyped a functional polymorphism in the

Indexed as

Alcohol DrinkingEndocannabinoidsAllelesArachidonic AcidsFatty Acid Amide HydrolasesHumansPolyunsaturated AlkamidesanandamideArachidonic AcidsEndocannabinoidsFatty Acid Amide HydrolasesPolyunsaturated Alkamidesalcoholismanandamideendocannabinoid systemfatty acid amide hydrolasehappinessPro129Thrrs324420

Identifiers

PMID37761966
PMCPMC10530831
OpenAlexW4386934974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.